Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody
- 18 May 2009
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 27 (23), 3072-3082
- https://doi.org/10.1016/j.vaccine.2009.03.019
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Immunogenicity of Influenza Virus Vaccine Is Increased by Anti-Gal-Mediated Targeting to Antigen-Presenting CellsJournal of Virology, 2007
- Increased Immunogenicity of Human Immunodeficiency Virus gp120 Engineered To Express Galα1-3Galβ1-4GlcNAc-R EpitopesJournal of Virology, 2006
- The influence of natural antibody specificity on antigen immunogenicityEuropean Journal of Immunology, 2005
- Immunobiology of Dendritic CellsAnnual Review of Immunology, 2000
- LacZ inducible, antigen/MHC-specific T cell hybridsInternational Immunology, 1994
- Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humansImmunology Today, 1993
- Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies.The Journal of Experimental Medicine, 1991
- A unique natural human IgG antibody with anti-alpha-galactosyl specificity.The Journal of Experimental Medicine, 1984
- Antibodies to Hepatitis B Surface Antigen Potentiate the Response of Human T Lymphocyte Clones to the Same AntigenScience, 1984
- Inactivated Venezuelan Equine Encephalomyelitis Virus Vaccine Complexed with Specific Antibody: Enhanced Primary Immune Response and Altered Pattern of Antibody Class ElicitedThe Journal of Infectious Diseases, 1977